MaltSci 麦伴科研

Appearance

Popular Reports / metabolism

This report is written by MaltSci based on the latest literature and research findings

What are the mechanisms of lipid metabolism disorders? ​

Abstract ​

Lipid metabolism disorders represent a significant public health challenge, intricately linked to various metabolic diseases such as obesity, diabetes, cardiovascular diseases, and non-alcoholic fatty liver disease (NAFLD). These disorders arise from an imbalance in lipid synthesis, storage, and degradation, leading to lipid accumulation in non-adipose tissues and subsequent metabolic dysfunction. This report provides a comprehensive overview of the mechanisms underlying lipid metabolism disorders, highlighting the roles of genetic mutations, hormonal regulation, and environmental factors in lipid dysregulation. Key lipid classes, including triglycerides, phospholipids, and sterols, are discussed in relation to their physiological functions and the pathological consequences of their dysregulation. Genetic factors, such as mutations in lipid metabolism-related genes and epigenetic modifications, contribute to hereditary lipid disorders and complex polygenic interactions. Hormonal regulation by insulin, glucagon, and other hormones is critical in maintaining lipid homeostasis, with dysregulation leading to conditions such as insulin resistance and metabolic syndrome. Environmental influences, particularly dietary patterns and physical activity, significantly impact lipid metabolism, with high-fat diets and sedentary lifestyles exacerbating metabolic disorders. Therapeutic approaches are explored, including pharmacological interventions and lifestyle modifications aimed at restoring lipid balance. The report emphasizes the importance of understanding these mechanisms to develop effective prevention and treatment strategies for lipid metabolism disorders, ultimately improving health outcomes for affected individuals.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Overview of Lipid Metabolism
    • 2.1 Lipid Classes and Functions
    • 2.2 Key Pathways in Lipid Metabolism
  • 3 Genetic Mechanisms of Lipid Metabolism Disorders
    • 3.1 Genetic Mutations and Variants
    • 3.2 Hereditary Disorders of Lipid Metabolism
  • 4 Hormonal Regulation of Lipid Metabolism
    • 4.1 Role of Insulin and Glucagon
    • 4.2 Impact of Other Hormones (e.g., Leptin, Ghrelin)
  • 5 Environmental and Lifestyle Factors
    • 5.1 Diet and Nutrition
    • 5.2 Physical Activity and Sedentary Behavior
  • 6 Therapeutic Approaches to Managing Lipid Metabolism Disorders
    • 6.1 Pharmacological Interventions
    • 6.2 Lifestyle Modifications and Dietary Approaches
  • 7 Summary

1 Introduction ​

Lipid metabolism disorders have emerged as a critical public health concern, closely linked to a range of metabolic diseases including obesity, diabetes, cardiovascular diseases, and fatty liver disease. These disorders arise from an imbalance in the intricate processes of lipid synthesis, storage, and degradation, leading to the accumulation of lipids in various tissues and consequent metabolic dysfunction. Understanding the mechanisms underlying these disorders is paramount for developing effective therapeutic strategies that can mitigate their impact on public health. Recent advancements in molecular biology and biochemistry have provided significant insights into the pathways and regulatory networks governing lipid metabolism, revealing the complex interplay between genetic, hormonal, and environmental factors that contribute to lipid dysregulation[1][2].

The significance of lipid metabolism extends beyond energy storage and membrane structure; it plays a vital role in cellular signaling and homeostasis. Dysregulated lipid metabolism can lead to pathological conditions such as insulin resistance, inflammation, and oxidative stress, which are hallmarks of various metabolic disorders[3][4]. For instance, the accumulation of lipids in non-adipose tissues, a phenomenon known as lipotoxicity, has been implicated in the progression of diseases like non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases[4][5]. Furthermore, recent studies have highlighted the role of gut microbiota in modulating lipid metabolism, illustrating the multifaceted nature of lipid homeostasis and its susceptibility to external influences such as diet and lifestyle[6].

Currently, research in lipid metabolism is rapidly evolving, with a focus on elucidating the molecular mechanisms that drive lipid dysregulation. Genetic factors, such as mutations in lipid metabolism-related genes, have been identified as contributors to hereditary lipid disorders[7][8]. Additionally, hormonal regulation, particularly the roles of insulin, glucagon, and other hormones, has been shown to significantly influence lipid metabolism pathways[1]. Environmental factors, including dietary habits and physical activity levels, also play a crucial role in shaping lipid metabolism and its associated disorders[2][9].

This report is organized into several key sections that provide a comprehensive overview of lipid metabolism and its disorders. The first section will detail the classes of lipids and their functions, followed by an exploration of the key metabolic pathways involved in lipid metabolism. The subsequent sections will delve into the genetic mechanisms of lipid metabolism disorders, examining genetic mutations and hereditary conditions that affect lipid homeostasis. The hormonal regulation of lipid metabolism will be discussed next, highlighting the roles of insulin, glucagon, and other hormones in lipid metabolism. Environmental and lifestyle factors will also be analyzed, emphasizing the impact of diet and physical activity on lipid homeostasis.

The report will further explore therapeutic approaches to managing lipid metabolism disorders, discussing pharmacological interventions as well as lifestyle modifications and dietary strategies aimed at restoring lipid balance. Finally, the report will summarize the findings and propose potential avenues for future research and therapeutic development in the field of lipid metabolism.

In conclusion, understanding the mechanisms of lipid metabolism disorders is essential for addressing the growing burden of metabolic diseases. By synthesizing current research findings and exploring the multifactorial nature of lipid dysregulation, this report aims to contribute to the development of effective strategies for the prevention and treatment of lipid metabolism disorders, ultimately improving health outcomes for affected individuals.

2 Overview of Lipid Metabolism ​

2.1 Lipid Classes and Functions ​

Lipid metabolism is a critical biological process that maintains cellular functions and energy homeostasis. Dysregulation of lipid metabolism can lead to various disorders, which are implicated in the pathogenesis of numerous diseases. The mechanisms underlying lipid metabolism disorders are multifaceted and involve several key lipid classes and their functions.

Lipid metabolism encompasses the synthesis, degradation, and transport of lipids, which include triglycerides, phospholipids, sphingolipids, and sterols. Each class of lipids plays distinct roles in cellular physiology and pathophysiology. For instance, triglycerides serve as a major energy storage form, while phospholipids are essential components of cellular membranes, contributing to membrane fluidity and signaling. Sphingolipids are involved in cell signaling and the regulation of cellular processes, while sterols, such as cholesterol, are vital for membrane integrity and serve as precursors for steroid hormones.

Disorders in lipid metabolism can arise from genetic mutations, environmental factors, and lifestyle choices, leading to altered lipid profiles and functions. For example, lipid metabolism disorders can result in the accumulation of lipids in non-adipose tissues, a phenomenon known as lipotoxicity, which can cause cellular dysfunction and inflammation. This is particularly evident in conditions such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD), where excessive lipid accumulation leads to insulin resistance and metabolic syndrome[10].

Mechanistically, lipid metabolism disorders may involve several pathways. Dysregulated lipid synthesis and degradation can lead to an imbalance in lipid homeostasis. For instance, excessive lipogenesis and inadequate lipolysis can result in the accumulation of triglycerides and free fatty acids, contributing to steatosis in the liver[11]. Additionally, endoplasmic reticulum (ER) stress and mitochondrial dysfunction are frequently associated with lipid metabolism disorders. ER stress can activate inflammatory pathways, further exacerbating metabolic dysregulation[5].

The role of autophagy in lipid metabolism is also crucial. Autophagy, particularly lipophagy, is the selective degradation of lipid droplets and is essential for maintaining lipid homeostasis. Dysregulation of autophagy can impair lipid metabolism and contribute to the development of metabolic diseases[12].

Moreover, the gut microbiota has emerged as a significant player in lipid metabolism. It influences lipid absorption, metabolism, and storage, and dysbiosis can disrupt these processes, leading to metabolic disorders such as obesity and NAFLD[6].

In summary, lipid metabolism disorders arise from complex interactions between genetic, environmental, and lifestyle factors, affecting various lipid classes and their physiological functions. Understanding these mechanisms is essential for developing targeted therapies for metabolic diseases associated with lipid dysregulation.

2.2 Key Pathways in Lipid Metabolism ​

Lipid metabolism is a critical biological process essential for maintaining cellular functions and energy homeostasis. Dysregulation of lipid metabolism is associated with various conditions, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. The mechanisms underlying lipid metabolism disorders are complex and multifaceted, involving a variety of pathways and factors that contribute to the pathogenesis of related diseases.

One of the key mechanisms involves the disruption of lipid deposition and transport processes. Lipid metabolism disorders can lead to abnormal lipid concentrations and impaired lipid transport, which critically impact the structure and function of various tissues. For instance, in ocular diseases, such as diabetic retinopathy and age-related macular degeneration, lipid deposition and disrupted cholesterol synthesis have been shown to induce oxidative stress, disrupt signal transduction, and lead to apoptosis of ocular tissue cells, ultimately contributing to the onset of these conditions [2].

Furthermore, the role of specific lipid species, such as triglycerides, phospholipids, sphingolipids, and sterols, is vital in cellular physiology and pathophysiology. For example, excessive accumulation of lipids can result in lipotoxicity, which impairs cellular function and alters metabolic pathways in various organs, including the liver, heart, and skeletal muscle [13]. This condition is often exacerbated by factors such as high-fat diets, insulin resistance, and oxidative stress, leading to metabolic disorders like obesity and type 2 diabetes [8].

The interplay between lipid metabolism and autophagy also plays a significant role in maintaining lipid homeostasis. Dysregulated autophagy, particularly the selective degradation of lipid droplets (lipophagy), has been implicated in metabolic disorders, indicating that disturbances in this process can contribute to conditions such as obesity and atherosclerosis [12]. Peroxisome proliferator-activated receptors (PPARs) serve as intracellular lipid sensors and regulators of gene expression, influencing both lipid metabolism and autophagy [12].

In addition, genetic and environmental factors contribute to lipid dysregulation. For instance, studies have shown that specific genetic mutations can affect lipid metabolism pathways, leading to disorders such as lipid storage myopathies, which are characterized by the accumulation of triglycerides in skeletal muscle [14]. Environmental factors, including dietary habits and exposure to pollutants, also play a critical role in lipid metabolism disorders, as they can alter lipid profiles and metabolic responses [15].

Moreover, emerging evidence suggests that gut microbiota significantly influences lipid metabolism. The gut microbiota regulates host lipid dynamics through various mechanisms, including the modulation of lipid absorption and metabolism, which can impact systemic metabolic outputs. Dysbiosis, or the imbalance of gut microbiota, has been linked to metabolic disorders such as obesity and non-alcoholic fatty liver disease (NAFLD) [6].

Overall, the mechanisms of lipid metabolism disorders encompass a complex interplay of metabolic pathways, cellular processes, and external factors, highlighting the need for a comprehensive understanding of these interactions to develop effective therapeutic strategies for related diseases.

3 Genetic Mechanisms of Lipid Metabolism Disorders ​

3.1 Genetic Mutations and Variants ​

Lipid metabolism disorders can arise from a variety of genetic mechanisms, including mutations and variants that affect key genes involved in lipid homeostasis. These genetic factors play a significant role in the pathogenesis of various lipid-related diseases, including hypercholesterolemia, dyslipidemia, and lipid storage myopathies.

A comprehensive review of the genetic determinants of inherited susceptibility to hypercholesterolemia highlights that mutations in four primary genes—LDLR, APOB, PCSK9, and LDLRAP1—account for the majority of familial hypercholesterolemia cases. However, a significant proportion of adults with hypercholesterolemia do not present mutations in these genes, suggesting a polygenic inheritance pattern involving additional genes that contribute to lipid metabolism [16]. Genome-wide association studies (GWAS) have identified nearly 80 genes associated with lipid metabolism, indicating a complex interplay of genetic variants that can disrupt lipid homeostasis and lead to disorders [16].

In the context of lipid storage myopathies, defects in lipid metabolism can affect the mitochondrial transport and oxidation of fatty acids or the catabolism of triglycerides, resulting in energy production impairments. These disorders often involve skeletal muscle, leading to progressive myopathy characterized by muscle weakness or acute rhabdomyolysis episodes triggered by various stressors [14]. Recent studies have also uncovered unusual pathogenic mechanisms and novel pharmacological approaches targeting these metabolic defects [14].

Furthermore, the role of DNA methylation as an epigenetic mechanism influencing lipid metabolism has been increasingly recognized. Research indicates that specific DNA methylation markers are associated with blood lipid levels and lipid-related phenotypes, suggesting that epigenetic changes can impact lipid metabolism and may be involved in the etiology of lipid disorders [17]. Integrating epigenome-wide association studies with other molecular data can elucidate causal relationships and reveal how these epigenetic modifications contribute to lipid dysregulation [17].

Additionally, the sphingolipid metabolic pathway has been implicated in various genetic disorders due to mutations affecting both lysosomal degradation and de novo synthesis of sphingolipids. These disorders can lead to the accumulation of toxic lipids and disrupt essential cellular processes, emphasizing the diverse genetic factors that can underlie lipid metabolism disorders [18].

Overall, the genetic landscape of lipid metabolism disorders is complex, involving multiple genes and regulatory mechanisms. This complexity highlights the necessity for ongoing research to better understand the genetic underpinnings of these disorders and to develop targeted therapeutic strategies.

3.2 Hereditary Disorders of Lipid Metabolism ​

Lipid metabolism disorders can arise from various genetic mechanisms, contributing to a range of hereditary conditions that affect lipid processing in the body. These disorders are characterized by the dysregulation of lipid metabolism, which can lead to significant health issues such as cardiovascular diseases, metabolic syndromes, and other metabolic disorders.

Genetic factors play a crucial role in lipid metabolism. Recent studies have identified several genetic loci associated with lipid metabolism disorders. For instance, research has revealed that mutations in genes responsible for lipid transport and metabolism can lead to conditions such as familial hypercholesterolemia and various lipodystrophies. These mutations disrupt normal lipid processing, resulting in abnormal lipid levels in the blood and altered fat distribution in tissues.

Laminopathies, a group of rare genetic disorders caused by mutations in the LMNA gene, exemplify the complex relationship between genetic mutations and lipid metabolism. These disorders, including Hutchinson-Gilford progeria syndrome and familial partial lipodystrophy, are characterized by disrupted adipose tissue function and metabolic regulation. Such disruptions lead to metabolic pathway dysfunctions, including insulin resistance, hypertriglyceridemia, and hepatic steatosis, which elevate the risk of developing cardiovascular diseases and diabetes (Krüger et al., 2024) [19].

In addition to single-gene disorders, polygenic influences are also significant in lipid metabolism. The interaction between multiple genetic variants and environmental factors, such as diet, contributes to the variability in lipid metabolism among individuals. This variability underscores the importance of personalized medicine approaches in managing lipid-related disorders, as the response to dietary interventions can differ significantly based on genetic background (Garcia-Rios et al., 2012) [20].

Moreover, epigenetic modifications, particularly DNA methylation, have been shown to influence lipid metabolism. These modifications can affect gene expression related to lipid processing and may be involved in the pathogenesis of lipid metabolism disorders. For instance, studies have identified specific methylation markers associated with lipid levels and related phenotypes, suggesting that epigenetic changes can be both a consequence and a cause of dyslipidemia (Mittelstraß & Waldenberger, 2018) [17].

The understanding of these genetic and epigenetic mechanisms is essential for the development of effective diagnostic and therapeutic strategies. Recent advancements in lipid-lowering therapies and the exploration of personalized nutrition highlight the potential for targeted interventions that consider individual genetic profiles and metabolic responses (Dakal et al., 2025) [1].

In summary, lipid metabolism disorders are intricately linked to genetic mechanisms, including single-gene mutations, polygenic influences, and epigenetic modifications. These genetic factors contribute to a variety of hereditary lipid metabolism disorders, underscoring the complexity of lipid regulation and the need for personalized approaches in treatment and management.

4 Hormonal Regulation of Lipid Metabolism ​

4.1 Role of Insulin and Glucagon ​

Lipid metabolism is a highly regulated process essential for maintaining cellular functions and energy homeostasis. Dysregulation of lipid metabolism is implicated in various metabolic disorders, including obesity, diabetes, and cardiovascular diseases. Hormonal regulation plays a pivotal role in lipid metabolism, particularly through the actions of insulin and glucagon.

Insulin is a key anabolic hormone that regulates lipid metabolism by promoting lipogenesis (the synthesis of fatty acids and triglycerides) and inhibiting lipolysis (the breakdown of fat). Insulin facilitates the uptake of glucose and fatty acids into adipocytes, where they are converted into triglycerides for storage. It also enhances the activity of lipoprotein lipase, an enzyme that hydrolyzes triglycerides in circulating lipoproteins, allowing for the uptake of free fatty acids by tissues. In contrast, insulin resistance, a condition frequently associated with obesity and metabolic syndrome, impairs these actions, leading to increased lipolysis and elevated levels of circulating free fatty acids, which can exacerbate insulin resistance and further dysregulate lipid metabolism[21].

Glucagon, on the other hand, is primarily known for its role in counteracting insulin's effects, particularly during fasting states. It stimulates lipolysis in adipose tissue, leading to the release of free fatty acids into the bloodstream. Glucagon acts on its receptors in the liver to promote gluconeogenesis and ketogenesis, processes that are critical for maintaining glucose levels during periods of low carbohydrate availability. Recent studies have also highlighted glucagon's involvement in other metabolic processes, including fat oxidation and appetite regulation, indicating its broader role in energy balance[22].

The interplay between insulin and glucagon is crucial for maintaining lipid homeostasis. When insulin levels are high, as in the postprandial state, lipogenesis is favored, and lipid storage is promoted. Conversely, during fasting or low-carbohydrate conditions, glucagon levels rise, promoting lipolysis and fatty acid oxidation. This delicate balance is disrupted in metabolic disorders, where either insulin resistance or glucagon overactivity can lead to lipid accumulation and associated pathologies[1].

In addition to insulin and glucagon, other hormones such as cortisol, catecholamines, and thyroid hormones also significantly influence lipid metabolism. Cortisol, for instance, promotes lipolysis and can lead to increased free fatty acid levels during stress, while thyroid hormones are essential for normal metabolic rate and lipid utilization. Dysregulation of these hormonal pathways can contribute to the pathogenesis of metabolic disorders, emphasizing the need for a comprehensive understanding of hormonal interactions in lipid metabolism[23].

In conclusion, the mechanisms underlying lipid metabolism disorders are multifaceted, involving a complex interplay of hormonal signals that regulate lipogenesis, lipolysis, and overall energy balance. Understanding these mechanisms is crucial for developing targeted therapeutic strategies for managing metabolic diseases associated with lipid dysregulation.

4.2 Impact of Other Hormones (e.g., Leptin, Ghrelin) ​

Lipid metabolism is a highly regulated process essential for maintaining cellular functions and energy homeostasis. Dysregulation of lipid metabolism is associated with various conditions, including cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. The mechanisms underlying lipid metabolism disorders are multifactorial, involving hormonal regulation, genetic predispositions, and environmental factors.

Hormones such as leptin and ghrelin play crucial roles in the regulation of lipid metabolism. Leptin, a hormone secreted by adipocytes, primarily functions as an anti-obesity hormone by suppressing appetite, reducing food intake, and increasing energy expenditure. However, resistance to leptin, often observed in obesity, impairs its regulatory effects on energy balance, leading to excessive fat accumulation. This resistance is associated with altered expression of the leptin gene and its receptor, which can further exacerbate metabolic dysfunctions such as insulin resistance and dyslipidemia[24].

Ghrelin, on the other hand, is a gut-derived hormone that influences appetite regulation and energy balance. It is recognized for its role in meal initiation and has been shown to impact lipid metabolism directly in the liver. Ghrelin modulates various intracellular pathways that regulate lipid metabolism, inflammation, and fibrosis. In the context of nonalcoholic fatty liver disease (NAFLD), ghrelin has demonstrated hepatoprotective effects by reducing hepatocyte lipotoxicity through mechanisms such as autophagy and fatty acid β-oxidation, thereby potentially preventing the progression of NAFLD in patients with metabolic disorders[25].

The interplay between leptin and ghrelin in energy homeostasis is complex, as both hormones can exhibit resistance in the context of obesity. For instance, while leptin levels are often elevated in obese individuals, ghrelin levels are typically reduced. This dysregulation may contribute to the development and maintenance of obesity, as the normal signaling pathways for these hormones are disrupted[26].

Additionally, other hormonal influences on lipid metabolism cannot be overlooked. Insulin is a key regulator of fat synthesis and affects lipid metabolism by modulating the activity of various transcription factors. Thyroid hormones also play a significant role, with new insights suggesting that they influence mitochondrial function and lipid metabolism pathways[27]. The overall hormonal milieu, including glucocorticoids and sex hormones, contributes to metabolic imbalances that can lead to disorders such as metabolic dysfunction-associated steatotic liver disease (MASLD) and other dyslipidemias[23].

In summary, the mechanisms of lipid metabolism disorders involve a complex interplay of hormonal regulation, particularly through leptin and ghrelin, alongside genetic and environmental factors. The disruption of these hormonal pathways not only contributes to lipid dysregulation but also poses significant challenges for effective diagnosis and management of related metabolic disorders. Understanding these mechanisms is crucial for developing targeted therapeutic strategies to address lipid metabolism disorders and their associated complications.

5 Environmental and Lifestyle Factors ​

5.1 Diet and Nutrition ​

Lipid metabolism disorders are significantly influenced by environmental and lifestyle factors, particularly diet and nutrition. These disorders can lead to various pathological conditions through several mechanisms that affect lipid homeostasis and cellular function.

Firstly, the composition of dietary fats plays a crucial role in lipid metabolism. High intake of saturated fats and trans fats can lead to dyslipidemia, characterized by elevated levels of low-density lipoprotein (LDL) cholesterol and triglycerides, which are risk factors for cardiovascular diseases and metabolic disorders such as obesity and type 2 diabetes [1]. Additionally, diets high in refined carbohydrates and sugars can exacerbate insulin resistance, further disrupting lipid metabolism [13].

Moreover, the interaction between diet and gut microbiota significantly influences lipid metabolism. The gut microbiota can modulate lipid absorption and metabolism, impacting systemic lipid levels. Dysbiosis, or an imbalance in gut microbiota composition, has been linked to metabolic disorders, including non-alcoholic fatty liver disease (NAFLD) and obesity [6]. Gut microbiota-derived metabolites can affect lipid metabolic pathways, illustrating the complex interplay between diet, microbiota, and lipid homeostasis [6].

Furthermore, excessive caloric intake, particularly from high-fat diets, can lead to lipotoxicity, where excess lipids accumulate in non-adipose tissues such as the liver, heart, and skeletal muscle. This accumulation can trigger cellular stress responses, including endoplasmic reticulum (ER) stress and oxidative stress, contributing to inflammation and cellular dysfunction [5], [4]. For instance, lipotoxicity in the liver is associated with the progression of chronic liver diseases, highlighting the detrimental effects of unregulated lipid accumulation [5].

Another critical aspect is the role of autophagy in lipid metabolism. Autophagy, specifically lipophagy, is involved in the degradation of lipid droplets and maintaining lipid homeostasis. Dysregulation of autophagy can lead to impaired lipid metabolism and contribute to metabolic disorders [12]. Additionally, peroxisome proliferator-activated receptors (PPARs), which act as lipid sensors, regulate both lipid metabolism and autophagy, indicating a complex relationship between these processes [12].

Lastly, lifestyle factors such as physical activity are essential for maintaining lipid metabolism. Sedentary behavior is associated with increased fat accumulation and reduced lipid oxidation, which can exacerbate metabolic disorders [9]. Regular exercise promotes lipid mobilization and enhances insulin sensitivity, thereby improving lipid profiles [9].

In summary, lipid metabolism disorders are intricately linked to dietary patterns, gut microbiota interactions, caloric intake, autophagy, and lifestyle choices. These factors collectively influence lipid homeostasis and can lead to various metabolic diseases when dysregulated. Understanding these mechanisms provides insight into potential therapeutic strategies for managing lipid metabolism disorders and their associated health implications.

5.2 Physical Activity and Sedentary Behavior ​

Lipid metabolism disorders are influenced by various environmental and lifestyle factors, particularly physical activity and sedentary behavior. The interplay between these factors can significantly affect lipid profiles and overall metabolic health.

Sedentary behavior has been identified as a critical risk factor for cardiometabolic health, contributing to the development of chronic non-communicable diseases (NCDs) such as obesity, type 2 diabetes mellitus, and cardiovascular diseases. Prolonged periods of inactivity can lead to disturbances in lipid metabolism, which are associated with increased risks for these conditions [28]. Research indicates that sedentary behavior may impair lipid homeostasis by affecting lipid levels in the bloodstream, leading to alterations in high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, as well as triglycerides [29].

The mechanisms underlying these disturbances involve a complex interplay of metabolic pathways. For instance, sedentary behavior is linked to decreased insulin sensitivity, which in turn affects lipid metabolism by altering the regulation of fatty acid oxidation and synthesis. This can result in the accumulation of lipids within tissues, contributing to a pathological state known as lipotoxicity, characterized by endoplasmic reticulum stress and inflammation [30].

Physical activity, conversely, has been shown to have a protective effect on lipid metabolism. Engaging in regular moderate to intense physical activity can enhance HDL cholesterol levels and lower triglycerides. For example, studies have demonstrated that higher levels of physical activity are associated with improved lipid profiles, particularly in normal-weight individuals [31]. The mechanisms here may include increased energy expenditure, enhanced fatty acid oxidation, and improved insulin sensitivity, all of which contribute to a more favorable lipid metabolism [3].

Moreover, lifestyle factors such as diet also play a crucial role in modulating lipid metabolism. Diets rich in unhealthy fats and sugars can exacerbate lipid metabolism disorders, while specific dietary patterns, such as the Mediterranean diet, have been associated with beneficial effects on lipid profiles [32].

In summary, lipid metabolism disorders are significantly influenced by physical activity and sedentary behavior, with mechanisms including altered insulin sensitivity, fatty acid oxidation, and the inflammatory response. The integration of lifestyle modifications, including increasing physical activity and reducing sedentary time, is essential for managing lipid metabolism disorders and improving overall metabolic health [1][33].

6 Therapeutic Approaches to Managing Lipid Metabolism Disorders ​

6.1 Pharmacological Interventions ​

Lipid metabolism disorders are characterized by disruptions in the normal processes of lipid synthesis, transport, and degradation, which can lead to various pathological conditions. The mechanisms underlying these disorders are multifaceted and involve several biological pathways and factors.

One prominent mechanism is the dysregulation of lipid metabolism, which is closely associated with various conditions such as cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. Key lipid species, including triglycerides, phospholipids, sphingolipids, and sterols, play critical roles in cellular physiology and pathophysiology. Dysregulated lipid metabolism can result from genetic predispositions, environmental factors, and lifestyle choices, leading to the accumulation of lipids in inappropriate tissues and subsequent cellular dysfunction[1].

Another significant mechanism involves the interplay between lipid metabolism and inflammatory responses. For instance, lipid metabolism disorders can activate inflammatory pathways, leading to oxidative stress and apoptosis of cells in affected tissues. This is particularly evident in conditions such as intervertebral disc degeneration, where lipid metabolism disorder contributes to extracellular matrix degradation and cell apoptosis through mechanisms like endoplasmic reticulum stress and oxidative stress[3].

Furthermore, disruptions in autophagy and mitochondrial function are also implicated in lipid metabolism disorders. Autophagy, particularly lipophagy (the selective degradation of lipid droplets), is essential for maintaining lipid homeostasis. Dysregulation of autophagy can lead to lipid accumulation and metabolic dysfunction, contributing to the pathogenesis of metabolic diseases such as obesity and atherosclerosis[12].

Pharmacological interventions aimed at managing lipid metabolism disorders have gained significant attention. Recent advancements in lipid-lowering therapies, including PCSK9 inhibitors, ezetimibe, bempedoic acid, and olpasiran, provide promising treatment options for conditions such as hypercholesterolemia[1]. Additionally, natural compounds have been explored for their potential to target lipid metabolism pathways. For example, paeonol has been shown to ameliorate glucose and lipid metabolism disorders by activating the Akt signaling pathway, which plays a critical role in lipid homeostasis[34].

Moreover, the therapeutic potential of targeting long non-coding RNAs (lncRNAs) has been highlighted as a novel approach for treating lipid-related diseases. These molecules can regulate lipid metabolism by modulating the expression of genes involved in lipid synthesis and transport[7].

In summary, the mechanisms of lipid metabolism disorders are complex and involve various biological pathways, including lipid dysregulation, inflammatory responses, and autophagy dysfunction. Therapeutic approaches, particularly pharmacological interventions targeting these pathways, hold promise for managing lipid metabolism disorders and improving patient outcomes.

6.2 Lifestyle Modifications and Dietary Approaches ​

Lipid metabolism disorders are characterized by the dysregulation of lipid homeostasis, which can lead to a variety of health issues, including cardiovascular diseases, metabolic syndromes, and ocular diseases. The mechanisms underlying these disorders are multifaceted and involve several biochemical pathways and cellular processes.

One primary mechanism is the disruption of lipid deposition and transport. Lipid metabolism disorders can lead to excessive lipid accumulation in tissues, resulting in lipotoxicity, which negatively affects cellular function. This condition is often exacerbated by factors such as obesity, sedentary lifestyles, and dietary choices high in saturated fats. For instance, dyslipidemia is frequently observed in patients with chronic kidney disease, where prolonged metabolic imbalances lead to ectopic fat distribution in organs like the heart and skeletal muscle, thereby accelerating inflammation and tissue damage[5].

Another critical aspect of lipid metabolism disorders involves the alteration of signaling pathways. For example, the activation of inflammatory responses and oxidative stress is linked to lipid metabolism abnormalities, which can result in apoptosis of ocular tissue cells and contribute to diseases such as age-related macular degeneration and diabetic retinopathy[2]. Additionally, the peroxisome proliferator-activated receptor (PPAR) signaling pathway plays a vital role in regulating lipid metabolism and autophagy, indicating that disruptions in these pathways can lead to metabolic disorders[12].

Therapeutic approaches to managing lipid metabolism disorders often include pharmacological interventions aimed at regulating lipid levels and improving metabolic function. Recent advancements in lipid-lowering therapies, such as PCSK9 inhibitors and ezetimibe, have shown promise in treating dyslipidemia, but they are accompanied by challenges related to cost and patient adherence[1]. Furthermore, targeting molecular pathways involved in lipid metabolism, such as autophagy and mitochondrial function, has emerged as a potential strategy for therapeutic management[35].

Lifestyle modifications and dietary approaches are also crucial in managing lipid metabolism disorders. Implementing a balanced diet low in saturated fats and rich in omega-3 fatty acids can help restore lipid homeostasis. Regular physical activity is essential for enhancing lipid oxidation and improving insulin sensitivity, thereby mitigating the risk of developing associated metabolic disorders[13]. Additionally, interventions that focus on weight management and physical fitness can significantly reduce the risk of developing conditions like type 2 diabetes and cardiovascular diseases[9].

In conclusion, lipid metabolism disorders result from complex interactions between genetic, environmental, and lifestyle factors. Effective management requires a multifaceted approach that includes pharmacological treatment, lifestyle modifications, and dietary changes to restore lipid balance and prevent the progression of related diseases. Understanding the underlying mechanisms of lipid metabolism is essential for developing targeted therapeutic strategies and improving patient outcomes.

7 Conclusion ​

The mechanisms underlying lipid metabolism disorders are complex and multifaceted, involving intricate interactions between genetic, hormonal, and environmental factors. Key findings indicate that genetic mutations in lipid metabolism-related genes, such as LDLR and APOB, significantly contribute to hereditary lipid disorders, while epigenetic modifications further complicate the landscape of lipid regulation. Hormonal factors, particularly insulin and glucagon, play crucial roles in maintaining lipid homeostasis, and their dysregulation is often implicated in metabolic disorders like obesity and type 2 diabetes. Additionally, lifestyle factors such as diet and physical activity have profound effects on lipid metabolism, influencing both the development and progression of lipid-related diseases. The current research highlights the need for a comprehensive understanding of these mechanisms to inform effective therapeutic strategies. Future research directions should focus on elucidating the role of gut microbiota in lipid metabolism, exploring novel pharmacological interventions targeting lipid dysregulation, and developing personalized lifestyle modification programs tailored to individual genetic and metabolic profiles. Ultimately, advancing our knowledge in this field is essential for mitigating the public health burden associated with lipid metabolism disorders and improving health outcomes for affected individuals.

References ​

  • [1] Tikam Chand Dakal;Feng Xiao;Chandra Kanta Bhusal;Poorna Chandrika Sabapathy;Rakesh Segal;Juan Chen;Xiaodong Bai. Lipids dysregulation in diseases: core concepts, targets and treatment strategies.. Lipids in health and disease(IF=4.2). 2025. PMID:39984909. DOI: 10.1186/s12944-024-02425-1.
  • [2] Yuanting Yang;Ruixue Zhang;Miao Zhang;Zhaohui Yang;Zhongyu Ma;Yinqiao Zhang;Mengke Wu;Dadong Guo;Hongsheng Bi. Association between Disorders of Lipid Metabolism and Oculopathy: An Overview.. International journal of medical sciences(IF=3.2). 2025. PMID:41049435. DOI: 10.7150/ijms.116512.
  • [3] Jun Yi;Qingluo Zhou;Jishang Huang;Shuo Niu;Guanglin Ji;Tiansheng Zheng. Lipid metabolism disorder promotes the development of intervertebral disc degeneration.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie(IF=7.5). 2023. PMID:37651799. DOI: 10.1016/j.biopha.2023.115401.
  • [4] Amine Nehaoua;Amin Gasmi;Asma Gasmi Benahmed;Sadaf Noor;Geir Bjørklund. Lipid Biochemistry and its Role in Human Diseases.. Current medicinal chemistry(IF=3.5). 2025. PMID:39901552. DOI: 10.2174/0109298673351452241220071215.
  • [5] Hiroshi Nishi;Takaaki Higashihara;Reiko Inagi. Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction.. Nutrients(IF=5.0). 2019. PMID:31330812. DOI: 10.3390/nu11071664.
  • [6] Bingqing Hang;Yuhao Wang. Interplay between gut microbiota and intestinal lipid metabolism:mechanisms and implications.. Journal of Zhejiang University. Science. B(IF=4.9). 2025. PMID:41116206. DOI: 10.1631/jzus.B2500102.
  • [7] Shi-Feng Huang;Xiao-Fei Peng;Lianggui Jiang;Ching Yuan Hu;Wen-Chu Ye. LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases.. Frontiers in pharmacology(IF=4.8). 2021. PMID:34421622. DOI: 10.3389/fphar.2021.729745.
  • [8] Linna Xu;Qingqing Yang;Jinghua Zhou. Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease.. International journal of molecular sciences(IF=4.9). 2024. PMID:39126035. DOI: 10.3390/ijms25158465.
  • [9] Daniel F Markgraf;Hadi Al-Hasani;Stefan Lehr. Lipidomics-Reshaping the Analysis and Perception of Type 2 Diabetes.. International journal of molecular sciences(IF=4.9). 2016. PMID:27827927. DOI: .
  • [10] Kai Liang;Jian-Ye Dai. Progress of potential drugs targeted in lipid metabolism research.. Frontiers in pharmacology(IF=4.8). 2022. PMID:36588702. DOI: 10.3389/fphar.2022.1067652.
  • [11] Tianjiao Li;Wei Guo;Zhanxiang Zhou. Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology.. Biomolecules(IF=4.8). 2021. PMID:35053204. DOI: 10.3390/biom12010057.
  • [12] Pouria Kiani;Elaheh Sadat Khodadadi;Ali Nikdasti;Sahar Yarahmadi;Mobina Gheibi;Zeynab Yousefi;Sajad Ehtiati;Sheida Yahyazadeh;Sayed Mohammad Shafiee;Motahareh Taghizadeh;Somayeh Igder;Seyyed Hossein Khatami;Saeed Karima;Omid Vakili;Morteza Pourfarzam. Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis.. Molecular and cellular biochemistry(IF=3.7). 2025. PMID:39891864. DOI: 10.1007/s11010-025-05207-0.
  • [13] Chiara Saponaro;Melania Gaggini;Fabrizia Carli;Amalia Gastaldelli. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.. Nutrients(IF=5.0). 2015. PMID:26580649. DOI: 10.3390/nu7115475.
  • [14] Claudio Bruno;Salvatore Dimauro. Lipid storage myopathies.. Current opinion in neurology(IF=4.4). 2008. PMID:18769256. DOI: 10.1097/WCO.0b013e32830dd5a6.
  • [15] Shuhui Liu;Zhangshan Gao;Wanqiu He;Yuting Wu;Jiwen Liu;Shuo Zhang;Liping Yan;Shengyong Mao;Xizhi Shi;Wentao Fan;Suquan Song. The gut microbiota metabolite glycochenodeoxycholate activates TFR-ACSL4-mediated ferroptosis to promote the development of environmental toxin-linked MAFLD.. Free radical biology & medicine(IF=8.2). 2022. PMID:36265794. DOI: 10.1016/j.freeradbiomed.2022.10.270.
  • [16] C S Paththinige;N D Sirisena;Vhw Dissanayake. Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.. Lipids in health and disease(IF=4.2). 2017. PMID:28577571. DOI: 10.1186/s12944-017-0488-4.
  • [17] Kirstin Mittelstraß;Melanie Waldenberger. DNA methylation in human lipid metabolism and related diseases.. Current opinion in lipidology(IF=4.6). 2018. PMID:29517982. DOI: 10.1097/MOL.0000000000000491.
  • [18] Teresa M Dunn;Cynthia J Tifft;Richard L Proia. A perilous path: the inborn errors of sphingolipid metabolism.. Journal of lipid research(IF=4.1). 2019. PMID:30683667. DOI: 10.1194/jlr.S091827.
  • [19] Peter Krüger;Ramona Hartinger;Karima Djabali. Navigating Lipodystrophy: Insights from Laminopathies and Beyond.. International journal of molecular sciences(IF=4.9). 2024. PMID:39125589. DOI: 10.3390/ijms25158020.
  • [20] Antonio Garcia-Rios;Pablo Perez-Martinez;Javier Delgado-Lista;Jose Lopez-Miranda;Francisco Perez-Jimenez. Nutrigenetics of the lipoprotein metabolism.. Molecular nutrition & food research(IF=4.2). 2012. PMID:22121097. DOI: 10.1002/mnfr.201100513.
  • [21] Rosa Isela Ortiz-Huidobro;Myrian Velasco;Carlos Larqué;Rene Escalona;Marcia Hiriart. Molecular Insulin Actions Are Sexually Dimorphic in Lipid Metabolism.. Frontiers in endocrinology(IF=4.6). 2021. PMID:34220716. DOI: 10.3389/fendo.2021.690484.
  • [22] Seung Hee Lee;Hyeon Young Park;Ji Ho Yun;Eun Kyoung Do. Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control.. Frontiers in endocrinology(IF=4.6). 2025. PMID:40822953. DOI: 10.3389/fendo.2025.1645041.
  • [23] Maria-Zinaida Dobre;Bogdana Virgolici;Ruxandra Cioarcă-Nedelcu. Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders.. Current issues in molecular biology(IF=3.0). 2025. PMID:40729034. DOI: 10.3390/cimb47070565.
  • [24] Miriam Jasim Shehab;Sarah T Al-Mofarji;Batool Mutar Mahdi;Rasha Sadeq Ameen;Mohammed Mahdi Al-Zubaidi. The correlation between obesity and leptin signaling pathways.. Cytokine(IF=3.7). 2025. PMID:40424747. DOI: 10.1016/j.cyto.2025.156970.
  • [25] Carlota Tuero;Sara Becerril;Silvia Ezquerro;Gabriela Neira;Gema Frühbeck;Amaia Rodríguez. Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression.. Journal of physiology and biochemistry(IF=4.3). 2023. PMID:36417140. DOI: 10.1007/s13105-022-00933-1.
  • [26] Huxing Cui;Miguel López;Kamal Rahmouni. The cellular and molecular bases of leptin and ghrelin resistance in obesity.. Nature reviews. Endocrinology(IF=40.0). 2017. PMID:28232667. DOI: 10.1038/nrendo.2016.222.
  • [27] Dengke Zhang;Yanghui Wei;Qingnan Huang;Yong Chen;Kai Zeng;Weiqin Yang;Juan Chen;Jiawei Chen. Important Hormones Regulating Lipid Metabolism.. Molecules (Basel, Switzerland)(IF=4.6). 2022. PMID:36296646. DOI: 10.3390/molecules27207052.
  • [28] Wouter M A Franssen;Ine Nieste;Kenneth Verboven;Bert O Eijnde. Sedentary behaviour and cardiometabolic health: Integrating the potential underlying molecular health aspects.. Metabolism: clinical and experimental(IF=11.9). 2025. PMID:40483777. DOI: 10.1016/j.metabol.2025.156320.
  • [29] Myung Ki;Theodora Pouliou;Leah Li;Chris Power. Physical (in)activity over 20 y in adulthood: associations with adult lipid levels in the 1958 British birth cohort.. Atherosclerosis(IF=5.7). 2011. PMID:21855876. DOI: 10.1016/j.atherosclerosis.2011.07.109.
  • [30] Michinari Nakamura. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques(IF=4.3). 2024. PMID:38706718. DOI: 10.3389/jpps.2024.12568.
  • [31] Georgina E Crichton;Ala'a Alkerwi. Physical activity, sedentary behavior time and lipid levels in the Observation of Cardiovascular Risk Factors in Luxembourg study.. Lipids in health and disease(IF=4.2). 2015. PMID:26256803. DOI: 10.1186/s12944-015-0085-3.
  • [32] Rosa Casas;Nancy D Sánchez-García;Ramon Estruch;Anallely López-Yerena. Impact of Dietary Interventions on the Human Plasma and Lipoprotein Lipidome.. Metabolites(IF=3.7). 2025. PMID:41002985. DOI: 10.3390/metabo15090602.
  • [33] Shixi Cao;Mengqi Liu;Yao Han;Shouren Li;Xiaoyan Zhu;Defeng Li;Yinghua Shi;Boshuai Liu. Effects of Saponins on Lipid Metabolism: The Gut-Liver Axis Plays a Key Role.. Nutrients(IF=5.0). 2024. PMID:38794751. DOI: 10.3390/nu16101514.
  • [34] Futian Xu;Haiming Xiao;Renbin Liu;Yan Yang;Meng Zhang;Lihao Chen;Zhiquan Chen;Peiqing Liu;Heqing Huang. Paeonol Ameliorates Glucose and Lipid Metabolism in Experimental Diabetes by Activating Akt.. Frontiers in pharmacology(IF=4.8). 2019. PMID:30941042. DOI: 10.3389/fphar.2019.00261.
  • [35] Guoxin Wang;Bingchan Sun;Huimin Liu;Min Hu;Huan Xu;Hongtao Li;Xijin Wang;Mingfu Tong. Interactions between lipid droplets and mitochondria in metabolic diseases.. Lipids in health and disease(IF=4.2). 2025. PMID:41219930. DOI: 10.1186/s12944-025-02759-4.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Lipid Metabolism · Metabolic Diseases · Genetic Mechanisms · Hormonal Regulation · Environmental Factors

© 2025 MaltSci